Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention: A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies

Study Questions:

What is the clinical benefit of statin pretreatment in the setting of percutaneous coronary intervention (PCI), in reducing periprocedural myocardial infarction (MI) and major adverse cardiac events (MACE) at 30 days?